BioBio ApS: Financial statements 2024
CVR: 42187542
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BioBio ApS (CVR 42187542) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -21,544 and a net result of DKK -21,169 compared with DKK 5,346 the year before. Equity in the 2024 report amounted to DKK 186,512. The solvency ratio was 77%.
- Gross Profit
- DKK -21,544
- Profit/Loss
- DKK -21,169
- Equity
- DKK 186,512
- Total Assets
- DKK 242,069
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -22K | -21K | 187K | - |
| 2023 | - | 9K | 5K | 208K | - |
| 2022 | - | 113K | 87K | 202K | - |
| 2021 | - | 107K | 75K | 115K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BioBio ApS has published its annual report for 2023. Gross profit came to DKK 9,049, and the net result was DKK 5,346.
About BioBio ApS
BioBio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2021. The company is registered under the industry Industrielt design og modedesign. The management consists of Katrine Helt Schaarup. The company is owned by Twenty/Twenty ApS. In 2025, the company reported a gross profit of DKK -25,354 and a net result of DKK -20,224 compared with DKK -21,169 the year before. Equity in the 2025 report amounted to DKK 166,288.